Myomo (MYO) Total Debt (2017 - 2025)

Myomo posted quarterly Total Debt of $2.7 million for Q4 2025, up 368.56% on a QoQ basis from $583333.0 in Q3 2025.

Myomo (MYO) has 5 years of Total Debt data on file, last reported at $2.7 million in Q4 2025.

For the quarter ending Q4 2025, Total Debt changed N/A year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (changed N/A YoY), and the FY2025 full-year result was $2.7 million, changed N/A from the prior year.
Total Debt for Q4 2025 stood at $2.7 million, up from $583333.0 in the prior quarter.
Across five years, Total Debt topped out at $2.7 million in Q4 2025 and bottomed at $583333.0 in Q3 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	34.05 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	14.72 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	28.07 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	10.13 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	1.93 Bn
10	Myomo	44.63 Mn	26.23 Mn	-	2.73 Mn

Download Data 🔒